PMID: 1200759Nov 1, 1975Paper

Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression

Archives of General Psychiatry
J W Maas

Abstract

Recent research findings indicate that depressive disorders may be divided into two groups, A and B, using specific biochemical and pharmacological criteria. It is suggested that in the A group there is a disorder of norepinephrine systems are not altered. Further, there is the possibility that B types patients have disorder of serotonin, but not norepinephrine or dopamine systems. This biochemical heterogeneity of human depression has implications for both investigators and clinicians, and may account for disparate findings in biological studies of patients with affective disorders.

Citations

Oct 1, 1978·Environmental Health Perspectives·I Hanin
Dec 13, 1995·Journal of Affective Disorders·R A BurnsM T Abou-Saleh
Mar 1, 1985·Journal of Neurology, Neurosurgery, and Psychiatry·J M Rabey, E Avrahami
Aug 1, 1984·Journal of Neurology, Neurosurgery, and Psychiatry·R A Brumback, H Wilson
Apr 1, 1997·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·A DubiniV Polin
Oct 1, 1987·The Journal of General Psychology·J J Askenasy
Jan 1, 1983·Progress in Neuro-psychopharmacology & Biological Psychiatry·S KelwalaN Sitaram
Aug 1, 1977·Psychological Medicine·P E Mullen, R E Silman
Jan 26, 2000·Comprehensive Psychiatry·M Bosc
Feb 1, 1993·Journal of Affective Disorders·O YaziciD Sahin
Nov 1, 1990·Journal of Affective Disorders·M GarveyV B Tuason
Aug 1, 1983·Journal of Affective Disorders·H A SternbachD R Sweeney
Sep 1, 1980·Journal of Affective Disorders·J W StewartD F Klein
Sep 6, 2012·Journal of the History of the Neurosciences·Shai Mulinari
Jan 1, 1979·Progress in Neuro-psychopharmacology·A CoppenA Jørgensen
Jan 1, 1979·Progress in Neuro-psychopharmacology·C L CazzulloE Smeraldi
Jan 1, 1986·Psychopharmacology·S Korsgaard, T Friis
Apr 11, 1979·Psychopharmacology·D E Casey
Jan 1, 1986·Psychopharmacology·B ScattonM F Poirier-Littre
Jun 19, 1978·European Journal of Clinical Pharmacology·C M Banki, M Vojnik
Jan 1, 1985·Applied Research in Mental Retardation·J L Matson
Jan 1, 1980·Psychoneuroendocrinology·A R GlassR C Dimond
Apr 1, 1985·The International Journal of Neuroscience·F J PirozzoloG J Maletta
Mar 1, 1986·The International Journal of Neuroscience·J S Han
Oct 1, 1980·Psychosomatics·M A Lipton
Jan 1, 1990·Movement Disorders : Official Journal of the Movement Disorder Society·M A MenzaR Duvoisin
Sep 1, 1990·Mayo Clinic Proceedings·E Richelson
Nov 1, 1995·Psychosomatics·M A MenzaL I Golbe
Apr 1, 1985·Journal of the American Academy of Dermatology·S L GreeneA L Schroeter
Jan 1, 1977·Journal of the American Academy of Child Psychiatry·D J Cohen, J G Young
Nov 1, 1987·Journal of the American Academy of Child and Adolescent Psychiatry·A U Khan
Nov 1, 1981·Journal of the American Academy of Dermatology·J E BernsteinK Soltani
May 15, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Yolande B SaabMatthew J Ingram
Mar 29, 2005·Clinical Psychology Review·Amy K CuellarRay Winters

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.